Pliant Therapeutics

Pliant Therapeutics is a clinical-stage biopharmaceutical company focused on discovering and developing novel integrin-based therapeutics. Its work targets a range of fibrotic diseases and oncology indications, operating at the intersection of drug discovery and clinical development.

The company's approach centers on integrin biology, a field with applications across multiple disease areas. Its pipeline addresses conditions characterized by fibrosis, as well as certain cancers, positioning it within two significant therapeutic areas of pharmaceutical research.

Pliant Therapeutics describes its culture as grounded in scientific rigor and collaborative innovation. The organization emphasizes internal and external knowledge sharing, pursuing scientific challenges with the stated aim of improving patient outcomes.